Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Cash and marketable securities position of $21.3M: Milestone

As well as the cash and outstanding license fee, the value of Avot, Crossflo, etc., must be included(less any liablities) to find the NAV or book value. There must also be a value attributable to future license fees.

On this basis, it would appear, in my very humble opinion, that the NAV is greater than the current share price. A highly unusual situation which will hopefully be corrected in the near term.

Think of it like going to the bank and paying, for example, 90 cents for each dollar withdrawn - go in with $900,00 and leave with $1,000,000.

I am also looking to some news from the USPTO in weeks rather than months.





Be well

Share
New Message
Please login to post a reply